000 01532 a2200421 4500
005 20250513203625.0
264 0 _c20000322
008 200003s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/(sici)1097-0215(20000215)85:4<527::aid-ijc14>3.0.co;2-#
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGangemi, R M
245 0 0 _aLate apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation.
_h[electronic resource]
260 _bInternational journal of cancer
_cFeb 2000
300 _a527-33 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCaspase 3
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDactinomycin
_xpharmacology
650 0 4 _aDocetaxel
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aHL-60 Cells
650 0 4 _aHumans
650 0 4 _aK562 Cells
650 0 4 _aKinetics
650 0 4 _aPaclitaxel
_xanalogs & derivatives
650 0 4 _aTaxoids
650 0 4 _aTime Factors
700 1 _aSantamaria, B
700 1 _aBargellesi, A
700 1 _aCosulich, E
700 1 _aFabbi, M
773 0 _tInternational journal of cancer
_gvol. 85
_gno. 4
_gp. 527-33
856 4 0 _uhttps://doi.org/10.1002/(sici)1097-0215(20000215)85:4<527::aid-ijc14>3.0.co;2-#
_zAvailable from publisher's website
999 _c10654023
_d10654023